Taken together, the facts that (1) GHSR is aberrantly hypermethylated in cancer specimens of different types, (2) its methylation levels accurately discriminate between cancer and control tissue specimens and (3) DNA methylation changes are detectable already in early stage tumors support a potentially high diagnostic value of GHSR methylation for a broad spectrum of malignancies. The gene discussed is GHSR; the disease is cancer.